BioSyntech, Inc.
BSYI · OTC
12/31/2009 | 9/30/2009 | 6/30/2009 | 3/31/2009 | |
|---|---|---|---|---|
| Market Cap | $11,655 | $11,836 | $12,007 | $15,529 |
| - Cash | $1,438 | $696 | $1,680 | $3,803 |
| + Debt | $17,298 | $14,366 | $12,648 | $12,079 |
| Enterprise Value | $27,515 | $25,506 | $22,975 | $23,805 |
| Revenue | $1 | $121 | $55 | $24 |
| % Growth | -99.6% | 119.2% | 132% | – |
| Gross Profit | -$0 | $82 | $33 | $17 |
| % Margin | -80.4% | 67.7% | 59.3% | 69.7% |
| EBITDA | -$3,251 | -$3,493 | -$2,519 | -$4,394 |
| % Margin | -638,779.8% | -2,898.3% | -4,582.1% | -18,540.1% |
| Net Income | -$3,380 | -$3,624 | -$2,660 | -$3,070 |
| % Margin | -664,083.3% | -3,007.2% | -4,837.7% | -12,955% |
| EPS Diluted | -0.032 | -0.032 | -0.035 | -0.031 |
| % Growth | 2.8% | 6.9% | -11.9% | – |
| Operating Cash Flow | -$1,556 | -$2,011 | -$1,912 | -$2,370 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1,562 | -$2,011 | -$1,912 | -$2,335 |